400
Participants
Start Date
December 31, 2022
Primary Completion Date
July 31, 2024
Study Completion Date
July 31, 2025
MM09 allergoid-mannan conjugates subcutaneous (3.000 UTm/mL)
Mixture of allergen extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae conjugated to mannan at 3.000 UTm/mL for subcutaneous administration.
MM09 allergoid-mannan conjugates Sublingual (3.000 UTm/mL)
Mixture of allergen extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae conjugated to mannan at 3.000 UTm/mL for sublingual administration.
MM09 allergoid-mannan conjugates Sublingual (9.000 UTm/mL)
Mixture of allergen extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae conjugated to mannan at 9.000 UTm/mL for sublingual administration.
Placebo subcutaneous
The same solution, presentation, method of administration, frequency, and duration as the active treatment, but without active ingredients.
Placebo sublingual
The same solution, presentation, method of administration, frequency, and duration as the active treatment, but without active ingredients.
Hospital Universitario de la Plana, Vila-real
Hospital Universitario A Coruña, A Coruña
Hopital Quirón Salud Málaga, Málaga
Clinica del Dr.Pérez Estrada Cornejo, Málaga
Hospital Universitario Regional de Málaga, Málaga
Hospital Universitario de Navarra, Pamplona
Complexo Hospitalario Universitario de Pontevedra, Pontevedra
Hospital Universitario de Canarias, San Cristóbal de La Laguna
Hospital Univeristario y Politécnico La Fe, Valencia
Clínica RUSADIR, Melilla
Hospital Universitario de Elche, Elche
Policlínica Nuestra Sra del Rosario, Ibiza Town
Hospital Sant Joan de Déu, Esplugues de Llobregat
Hospital de Terrassa, Terrassa
Hospital General Universitario de Alicante, Alicante
Centro Médico Quiron Salud Alicante, Alicante
Lead Sponsor
BioClever 2005 S.L.
OTHER
NTS hub S.L
UNKNOWN
Inmunotek S.L.
INDUSTRY